These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2942040

  • 1. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
    Gillespie MN, Olson JW, Reinsel CN, O'Connor WN, Altiere RJ.
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
    Hilliker KS, Roth RA.
    Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
    [Abstract] [Full Text] [Related]

  • 4. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ, Olson JW, Gillespie MN.
    J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats.
    Shubat PJ, Banner W, Huxtable RJ.
    Toxicon; 1987 Feb; 25(9):995-1002. PubMed ID: 3124302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs.
    Archer SL, Rist K, Nelson DP, DeMaster EG, Cowan N, Weir EK.
    J Appl Physiol (1985); 1990 Feb; 68(2):735-47. PubMed ID: 2156794
    [Abstract] [Full Text] [Related]

  • 8. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL, Olson JW, Gillespie MN.
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [Abstract] [Full Text] [Related]

  • 9. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
    Frasch HF, Marshall C, Marshall BE.
    Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN, Olson JW, Hennig B, Cohen DA, McClain CJ, Goldblum SE.
    Toxicol Appl Pharmacol; 1989 Mar 15; 98(1):134-43. PubMed ID: 2494779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U, Olson JW, Gillespie MN.
    Res Commun Chem Pathol Pharmacol; 1988 Nov 15; 62(2):187-94. PubMed ID: 3150791
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM, Keane PM, Suyama KL, Gauthier D.
    Thorax; 1982 Feb 15; 37(2):88-96. PubMed ID: 6281933
    [Abstract] [Full Text] [Related]

  • 15. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
    Colice GL, Hill N, Lee YJ, Du H, Klinger J, Leiter JC, Ou LC.
    J Appl Physiol (1985); 1997 Jul 15; 83(1):25-31. PubMed ID: 9216940
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
    Cassis LA, Rippetoe PE, Soltis EE, Painter DJ, Fitz R, Gillespie MN.
    J Pharmacol Exp Ther; 1992 Sep 15; 262(3):1168-72. PubMed ID: 1527721
    [Abstract] [Full Text] [Related]

  • 17. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan 15; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

  • 18. Effect of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats.
    Mathew R, Guzowski DE, Gloster ES.
    Exp Lung Res; 1990 Jan 15; 16(6):627-44. PubMed ID: 1964410
    [Abstract] [Full Text] [Related]

  • 19. [Pulmonary vasoconstrictor responses].
    Onodera S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec 15; 30 Suppl():15-25. PubMed ID: 1363972
    [Abstract] [Full Text] [Related]

  • 20. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 15; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.